CoChat

3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer’s disease

Open access

The DOI matches its Crossref record; 76 of the 77 references it cites were found in a registry or an index.

Abstract

Mild cognitive impairment (MCI), particularly the amnestic subtype (aMCI), is considered as a transitional stage between normal aging and a diagnosis of clinically probable Alzheimer's disease (AD). The aMCI construct is particularly useful as it provides an opportunity to assess a clinical stage which in most subjects represents prodromal AD. The aim of this study was to assess the progression of cerebral atrophy over multiple serial MRI during the period from aMCI to progression to AD. Thirty-three subjects were selected that fulfilled clinical criteria for aMCI and had three serial MRI scans: the first scan approximately 3 years before the diagnosis of AD, the second scan approximately 1 year before, and the third scan at the time of the diagnosis of AD. A group of 33 healthy controls were age and gender-matched to the study cohort. Voxel-based morphometry (VBM) was used to assess patterns of grey matter atrophy in the aMCI subjects at each time-point compared to the control group. Customized templates and prior probability maps were used to avoid normalization and segmentation bias. The pattern of grey matter loss in the aMCI subject scans that were 3 years before the diagnosis of AD was focused primarily on the medial temporal lobes, including the amygdala, anterior hippocampus and entorhinal cortex, with some additional involvement of the fusiform gyrus, compared to controls. The extent and magnitude of the cerebral atrophy further progressed by the time the subjects were 1 year before the diagnosis of AD. At this point atrophy in the temporal lobes spread to include the middle temporal gyrus, and extended into more posterior regions of the temporal lobe to include the entire extent of the hippocampus. The parietal lobe also started to become involved. By the time the subjects had progressed to a clinical diagnosis of AD the pattern of grey matter atrophy had become still more widespread with more severe involvement of the medial temporal lobes and the temporoparietal association cortices and, for the first time, substantial involvement of the frontal lobes. This pattern of progression fits well with the Braak and Braak neurofibrillary pathological staging scheme in AD. It suggests that the earliest changes occur in the anterior medial temporal lobe and fusiform gyrus, and that these changes occur at least 3 years before progression to the diagnosis of AD. These results also suggest that 3D patterns of grey matter atrophy may help to predict the time to the first diagnosis of AD in subjects with aMCI.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awm112

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Time-line representing the time of each MRI scan for each individual ( n ¼ 33) relative to progression from aMCI to a clinical diagnosis of AD. The black diamonds represent the scan at the time of the diagnosis of AD. The blue circles represent the scans classified as being 1 year (9^18 months) before the diagnosis of AD . The orange triangles represent the scans classified as being 3 years (18^51 months) before the diagnosis of AD.
Fig. 1 Time-line representing the time of each MRI scan for each individual ( n ¼ 33) relative to progression from aMCI to a clinical diagnosis of AD. The black diamonds represent the scan at the time of the diagnosis of AD. The blue circles represent the scans classified as being 1 year (9^18 months) before the diagnosis of AD . The orange triangles represent the scans classified as being 3 years (18^51 months) before the diagnosis of AD.CC-BY-NC · From the PDF
Fig. 2 Patterns of grey matter atrophy in the aMCI progressors  3 years (18^54 months) before progression to AD. The results are shown on a 3D surface render (top) and overlaid on representative axial, coronal and sagittal slices (bottom). L ¼ left; R ¼ right.
Fig. 2 Patterns of grey matter atrophy in the aMCI progressors  3 years (18^54 months) before progression to AD. The results are shown on a 3D surface render (top) and overlaid on representative axial, coronal and sagittal slices (bottom). L ¼ left; R ¼ right.CC-BY-NC · From the PDF
Fig. 3 Patterns of grey matter atrophy in the aMCI progressors  1 year (9^18 months) before progression to AD. The results are shown on a 3D surface render (top) and overlaid on representative axial, coronal and sagittal slices (bottom). L ¼ left; R ¼ right.
Fig. 3 Patterns of grey matter atrophy in the aMCI progressors  1 year (9^18 months) before progression to AD. The results are shown on a 3D surface render (top) and overlaid on representative axial, coronal and sagittal slices (bottom). L ¼ left; R ¼ right.CC-BY-NC · From the PDF
Fig. 4 Patterns of grey matter atrophy in the aMCI progressors at the time of a diagnosis of AD. The results are shown on a 3D surface render (top) and overlaid on representative axial, coronal and sagittal slices (bottom). L ¼ left; R ¼ right.
Fig. 4 Patterns of grey matter atrophy in the aMCI progressors at the time of a diagnosis of AD. The results are shown on a 3D surface render (top) and overlaid on representative axial, coronal and sagittal slices (bottom). L ¼ left; R ¼ right.CC-BY-NC · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 76 references

Research works printed but not linked: 3

  1. Chang F, LF, Parisi JE, Jack CR, Petersen RC. Morphometric analysis of the hippocampus in Alzheimer's disease: post-mortem MRI and histological correlates. Ann Neurol 1992; 32: 268.
  2. Dickerson BC, Goncharova I, Sullivan MP, Forchetti C, Wilson RS, Bennett DA, et al. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging 2001; 22: 747-54.
  3. Killiany RJ, Gomez-Isla T, Moss M, Kikinis R, Sandor T, Jolesz F, et al. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol 2000; 47: 430-9.

Cited by

See all 607

Metadata

Authors
Whitwell, J. L., Przybelski, S. A., Weigand, S. D., Knopman, D. S., Boeve, B. F., Petersen, R. C., & Jack, C. R.
Affiliations
Mayo Clinic (US)
Venue
Brain
Published
2007-05-29
Volume
130
Issue
7
Pages
1777-1786
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2159320983
Cited by
607
References
77
Citations by year
2026: 17 · 2025: 19 · 2024: 17 · 2023: 18 · 2022: 19 · 2021: 27 · 2020: 58 · 2019: 31 · 2018: 23 · 2017: 28 · 2016: 27 · 2015: 26 · 2014: 37 · 2013: 47 · 2012: 42
FWCI
24.83
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Brain (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • GlaxoSmithKline
  • Mayo Foundation for Medical Education and Research (AG16574)
  • National Institute on Aging (R01AG11378, P50‐AG16574, U01AG06786, AG 16574, U01AG006786, R01AG011378, AG-11378, P50AG016574)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
Keywords
mild cognitive impairment, amnestic mild cognitive impairment, Alzheimer's disease, gray matter atrophy, medial temporal lobe, hippocampus, entorhinal cortex, amygdala, fusiform gyrus, temporal lobe, parietal lobe, frontal lobe, prodromal Alzheimer's disease
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Atrophy, Brain, Brain Mapping, Cognition Disorders, Female, Humans, Image Processing, Computer-Assisted, Magnetic Resonance Imaging, Male, Middle Aged, Temporal Lobe, Disease Progression, Imaging, Three-Dimensional

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer’s disease. https://app.cochat.ai/papers/10.1093/brain/awm112
The paper
Whitwell, J. L., Przybelski, S. A., Weigand, S. D., Knopman, D. S., Boeve, B. F., Petersen, R. C., & Jack, C. R. (2007). 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer’s disease. Brain. https://doi.org/10.1093/brain/awm112

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.